Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Audit Finding: Data Integrity Gaps

GMP Non-Compliance: SOPs Missing Audit Trail Expectations

Posted on By

GMP Non-Compliance: SOPs Missing Audit Trail Expectations Data Integrity Violation: Missing Audit Trail Expectations in SOPs Introduction to the Audit Finding 1. Audit Finding Overview This compliance gap involves SOPs that do not include expectations for audit trail generation, review, or retention, particularly in computerized systems. 2. Relevance to Data Integrity An audit trail is…

Read More “GMP Non-Compliance: SOPs Missing Audit Trail Expectations” »

Data Integrity Gaps, GMP Audit Findings

GMP Violation: Absence of SOPs for Electronic Record Handling

Posted on By

GMP Violation: Absence of SOPs for Electronic Record Handling GMP Non-Compliance Due to Missing SOPs for Electronic Record Handling Introduction to the Audit Finding 1. Summary of Finding Electronic records critical to GMP operations are managed without documented procedures—violating data integrity expectations. 2. Data Governance Concern Without a defined SOP, electronic data becomes vulnerable to…

Read More “GMP Violation: Absence of SOPs for Electronic Record Handling” »

Data Integrity Gaps, GMP Audit Findings

No Policy for Electronic Signatures: A Data Integrity Red Flag in GMP Systems

Posted on By

No Policy for Electronic Signatures: A Data Integrity Red Flag in GMP Systems Missing Electronic Signature Policy: A Risk to Data Integrity and GMP Compliance Introduction to the Audit Finding 1. Undefined e-Signature Protocols Organizations lack written procedures governing electronic signatures used in GMP operations. 2. Violation of 21 CFR Part 11 Absence of a…

Read More “No Policy for Electronic Signatures: A Data Integrity Red Flag in GMP Systems” »

Data Integrity Gaps, GMP Audit Findings

Data Integrity Controls Missing in Process SOPs: A Critical GMP Risk

Posted on By

Data Integrity Controls Missing in Process SOPs: A Critical GMP Risk Absence of Data Integrity Controls in Process SOPs: GMP Compliance Jeopardized Introduction to the Audit Finding 1. Unstructured Data Handling Process SOPs often lack instructions on data capture, review, or archival in compliance with ALCOA principles. 2. Informal Record Practices Operators maintain critical records…

Read More “Data Integrity Controls Missing in Process SOPs: A Critical GMP Risk” »

Data Integrity Gaps, GMP Audit Findings

SOPs Don’t Define Time-Stamped Entry Protocols: A GMP Documentation Deficiency

Posted on By

SOPs Don’t Define Time-Stamped Entry Protocols: A GMP Documentation Deficiency Time-Stamped Entries Missing in SOPs: A Critical Data Integrity Lapse Introduction to the Audit Finding 1. Omission of Timestamp Procedures Many SOPs fail to instruct personnel to include dates and times when recording GMP data. 2. Traceability Risks Without timestamps, it is impossible to verify…

Read More “SOPs Don’t Define Time-Stamped Entry Protocols: A GMP Documentation Deficiency” »

Data Integrity Gaps, GMP Audit Findings

SOPs Lack Audit Trail Review Frequency: A Data Integrity Risk

Posted on By

SOPs Lack Audit Trail Review Frequency: A Data Integrity Risk GMP SOPs Missing Audit Trail Review Frequency: A Risk to Data Integrity Introduction to the Audit Finding 1. SOPs Don’t Specify Review Intervals Key SOPs for electronic systems often omit defined frequency for reviewing audit trails. 2. Regulatory Risk Exposure Without routine reviews, critical changes,…

Read More “SOPs Lack Audit Trail Review Frequency: A Data Integrity Risk” »

Data Integrity Gaps, GMP Audit Findings

No SOP for Electronic Record Review in QC Systems: A Data Integrity Violation

Posted on By

No SOP for Electronic Record Review in QC Systems: A Data Integrity Violation Missing SOP for QC Electronic Data Review: A Critical Regulatory Lapse Introduction to the Audit Finding 1. SOPs Missing for LIMS and QC Systems Many labs operate systems like LIMS, CDS, or ELN without SOPs guiding data review protocols. 2. Impact on…

Read More “No SOP for Electronic Record Review in QC Systems: A Data Integrity Violation” »

Data Integrity Gaps, GMP Audit Findings

Failure to Define Backup and Archival SOPs: A Data Integrity Concern

Posted on By

Failure to Define Backup and Archival SOPs: A Data Integrity Concern GMP Risk: Missing SOPs for Data Backup and Archival Procedures Introduction to the Audit Finding 1. No SOP for Data Backup In several GMP facilities, backup procedures for electronic records are either undocumented or loosely defined. 2. Archival Process Ambiguity Critical GMP records are…

Read More “Failure to Define Backup and Archival SOPs: A Data Integrity Concern” »

Data Integrity Gaps, GMP Audit Findings

No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap

Posted on By

No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap Missing Access Control Procedures for GMP Systems: A Risk to Data Integrity Introduction to the Audit Finding 1. No SOP for Access Rights GMP systems like LIMS, MES, or ERP lack written procedures to manage user access. 2. Role-Based Access Undefined There’s no…

Read More “No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap” »

Data Integrity Gaps, GMP Audit Findings

SOP Gaps in Data Correction Documentation: Risk to GMP Integrity

Posted on By

SOP Gaps in Data Correction Documentation: Risk to GMP Integrity GMP Risk: SOP Lacks Guidelines for Documenting Data Corrections Introduction to the Audit Finding 1. SOP Omits Correction Protocols Key GMP records are corrected without following any defined method or procedure. 2. No Consistency in Corrections Corrections vary between operators—some overwrite, others use white-out or…

Read More “SOP Gaps in Data Correction Documentation: Risk to GMP Integrity” »

Data Integrity Gaps, GMP Audit Findings

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme